Evidence map›Paper›PMID 33944776›Full record

ArticleeLife2021

Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3.

Francesco Beghini, Lauren J McIver, Aitor Blanco-Míguez, Leonard Dubois, Francesco Asnicar, Sagun Maharjan, Ana Mailyan, Paolo Manghi, Matthias Scholz, Andrew Maltez Thomas and 7 more

3 registry-linked trialsAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,509 papers.

0numbers the graph read from it
0cells of the map it votes in
1,509citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06588166 recruitingnot on this mapstarted 2024, after this paper: background citation

A Non-invasive Gut Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2024 to 2027Enrolled1,006ConditionsColorectal CancerArmsGut microbiome testing
NCT06738173 recruitingnot on this mapstarted 2025, after this paper: background citation

A Gut Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer

TypeobservationalSponsorCatholic University of the Sacred HeartRan2025 to 2029Enrolled1,202ConditionsColorectal CancerArmsGut microbiome testing
NCT06992453 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Disentangling Microbiome Engraftment by Multi-omics of the Gut Ecosystem During Fecal Transplant

TypeinterventionalSponsorCatholic University of the Sacred HeartRan2026 to 2029Enrolled90ConditionsRecurrent C. Difficile (rCDI), Ulcerative Colitis (UC), Metabolic Syndrome (MetS)ArmsFecal microbiota transplantation (FMT)
3 · Its place in the literature

Who cites it

1,509 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Testosterone administration partially modulates gut microbiota responses to severe energy deficit.American journal of physiology. Endocrinology and metabolism · 2026
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Oncoimmunology · 2026
    Article
  15. Article
  16. Article
  17. High dietary BGut microbes · 2026
    Article
  18. Article
  19. Gut microbes · 2026
    Article
  20. Article

1,449 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Francesco Beghini *Department CIBIO, University of Trento, Trento, Italy.ORCID 0000-0002-8105-9607
Lauren J McIver *Harvard T.H. Chan School of Public Health, Boston, United States.
Aitor Blanco-MíguezDepartment CIBIO, University of Trento, Trento, Italy.
Leonard DuboisDepartment CIBIO, University of Trento, Trento, Italy.ORCID 0000-0003-0322-482X
Francesco AsnicarDepartment CIBIO, University of Trento, Trento, Italy.
Sagun MaharjanHarvard T.H. Chan School of Public Health, Boston, United States.
Ana MailyanHarvard T.H. Chan School of Public Health, Boston, United States.
Paolo ManghiDepartment CIBIO, University of Trento, Trento, Italy.
Matthias ScholzDepartment of Food Quality and Nutrition, Research and Innovation Center, Edmund Mach Foundation, San Michele all'Adige, Italy.ORCID 0000-0003-1414-5924
Andrew Maltez ThomasDepartment CIBIO, University of Trento, Trento, Italy.
Mireia Valles-ColomerDepartment CIBIO, University of Trento, Trento, Italy.
George WeingartHarvard T.H. Chan School of Public Health, Boston, United States.
Yancong ZhangHarvard T.H. Chan School of Public Health, Boston, United States.ORCID 0000-0002-2768-2975
Moreno ZolfoDepartment CIBIO, University of Trento, Trento, Italy.ORCID 0000-0001-6661-4046
Curtis HuttenhowerHarvard T.H. Chan School of Public Health, Boston, United States.ORCID 0000-0002-1110-0096
Eric A FranzosaHarvard T.H. Chan School of Public Health, Boston, United States.ORCID 0000-0002-8798-7068
Nicola SegataDepartment CIBIO, University of Trento, Trento, Italy.ORCID 0000-0002-1583-5794

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
A comprehensive platform for novel therapy development from the microbiomeR24DK110499 · NIDDK · BROAD INSTITUTE, INC. · PI HUTTENHOWER, CURTIS · 2017 to 2021
$7.7M
Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome RelationshipsR01CA230551 · NCI · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI Levi Waldron · 2020 to 2026
$3.9M
Overcoming bias and unwanted variability in next generation sequencingR01HG005220 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI IRIZARRY, RAFAEL ANGEL · 2010 to 2018
$3.6M
Characterizing the gut microbial ecosystem for diagnosis and therapy in IBDU54DE023798 · NIDCR · BROAD INSTITUTE, INC. · PI HUTTENHOWER, CURTIS, XAVIER, RAMNIK J · 2013 to 2014
$3.0M
Exploiting public metagenomic data to uncover cancer-microbiome relationshipsU01CA230551 · NCI · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI WALDRON, LEVI · 2019 to 2019
$464k
Cancer Research UK C10674/A27140NCI NIH HHS R01 CA230551NCI NIH HHS U01 CA230551NHGRI NIH HHS R01 HG005220NIDCR NIH HHS U54 DE023798NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R24 DK110499
6 · The paper itself

Abstract

Culture-independent analyses of microbial communities have progressed dramatically in the last decade, particularly due to advances in methods for biological profiling via shotgun metagenomics. Opportunities for improvement continue to accelerate, with greater access to multi-omics, microbial reference genomes, and strain-level diversity. To leverage these, we present bioBakery 3, a set of integrated, improved methods for taxonomic, strain-level, functional, and phylogenetic profiling of metagenomes newly developed to build on the largest set of reference sequences now available. Compared to current alternatives, MetaPhlAn 3 increases the accuracy of taxonomic profiling, and HUMAnN 3 improves that of functional potential and activity. These methods detected novel disease-microbiome links in applications to CRC (1262 metagenomes) and IBD (1635 metagenomes and 817 metatranscriptomes). Strain-level profiling of an additional 4077 metagenomes with StrainPhlAn 3 and PanPhlAn 3 unraveled the phylogenetic and functional structure of the common gut microbe

Indexed as

MetagenomePhylogenyBacteriaComputational BiologyHumansMetagenomicsMicrobiotaResearch PersonnelRuminococcusWorkflowcomputational analysiscomputational biologyhumaninfectious diseasemetagenomicsmicrobial genomicsmicrobiologymicrobiomesystems biology

Identifiers

PMID33944776
PMCPMC8096432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.